Puberty and Growth
Presenter: Dr. Philippe Backeljauw, MSC, MD (Cincinnati Children's Hospital Medical Center)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Dr. Andrew Dauber, MD (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Tara McCarthy, BA (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Anqing Zhang, PhD (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Kimberly Boucher, RN (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Nadia Merchant, MD (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Niti Dham, MD (Children's National Hospital)
No relevant financial relationships

A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
Presenter: Roopa Kanakatti Shankar, MD (Children's National Hospital)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Dr. J Whitehead, MD (Lurie Children's Hospital/Northwestern University)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Lauren Mohnach, MS, CGC (C.S. Mott Children's Hospital/University of Michigan)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Catherine Keegan, MD, PhD (C.S. Mott Children's Hospital/University of Michigan)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: DSD-TRN Endocrine & Genetics Working Groups, . (DSD Translational Research Network)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Courtney Finlayson, MD (Lurie Children's Hospital/Northwestern University)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Ana Canton, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Ms. Flavia Tinano, MD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Luciana Montenegro, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Andrea Leal, MD, PhD (Universidade Estadual do Pará, Santarem, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Carolina Ramos, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Maiara Piovesan, BSc (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Carlos Seraphim, MD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Aline Guimaraes, MD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Berenice Mendonça, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Vinicius Brito, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Jesús Argente, MD, PhD (Hospital Infantil Universitario Niño Jesús. Universidad Autónoma de Madrid. CIBER fisiopatología de la obesidad y nutrición. Instituto de Salud Carlos III. IMDEA Instituto. Madrid, Spain.)
No relevant financial relationships

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
Presenter: Ana Claudia Latronico, MD, PhD (Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia e Metabologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Ron Newfield, MD (University of California San Diego and Rady Children’s Hospital)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Dr. Kyriakie Sarafoglou, MD (University of Minnesota Medical School)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Patricia Fechner, MD (University of Washington School of Medicine, Seattle Children’s Hospital)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Natalie Nokoff, MD (University of Colorado School of Medicine, Children’s Hospital Colorado)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Dr. Richard Auchus, MD (University of Michigan Medical School)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Maria Vogiatzi, MD (The Children’s Hospital of Philadelphia)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Nagdeep Giri, PhD (Neurocrine Biosciences, Inc.)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Eiry Roberts, MD (Neurocrine Biosciences, Inc.)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Julia Sturgeon, MS (Neurocrine Biosciences, Inc.)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Jean Chan, MD (Neurocrine Biosciences, Inc.)
No relevant financial relationships

Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
Presenter: Robert Farber, PhD (Neurocrine Biosciences, Inc.)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Dr. Stephanie Roberts, MD (Boston Children's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Kali McKnight, BA (Brigham and Women's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Lydie Naule, PhD (Brigham and Women's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Sidney Pereira, DVM, PhD (Brigham and Women's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Han Kyeol Kim, BA (Brigham and Women's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Miguel Sena-Esteves, PhD (University of Massachusetts Medical School)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Rona Carroll, PhD (Brigham and Women's Hospital)
No relevant financial relationships

The Impact of Makorin Ring Finger Protein 3 (MKRN3) Overexpression in the Arcuate Nucleus of Postpubertal Female Mice on the HPG Axis
Presenter: Ursula Kaiser, MD (Brigham and Women's Hospital)
No relevant financial relationships

Tracking the Diagnosis and Progression of Madelung Deformity in Pediatric Turner Syndrome Patients
Presenter: Mr. Alex Huron, Medical Student (University of Cincinnati College of Medicine)
No relevant financial relationships

Tracking the Diagnosis and Progression of Madelung Deformity in Pediatric Turner Syndrome Patients
Presenter: Kevin Little, MD (Cincinnati Children's Hospital Medical Center)
No relevant financial relationships

Tracking the Diagnosis and Progression of Madelung Deformity in Pediatric Turner Syndrome Patients
Presenter: Philippe F. Backeljauw, MD (Cincinnati Children's Hospital Medical Center)
No relevant financial relationships

Tracking the Diagnosis and Progression of Madelung Deformity in Pediatric Turner Syndrome Patients
Presenter: Iris Gutmark-Little, MD (Cincinnati Children's Hospital Medical Center)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Phyllis Speiser, MD (Northwell)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Deepa Mathew, DO (St. Luke's University Health Network)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Meilan Rutter, MD (Cincinnati Children's Hospital)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Tara Schafer-Kalkhoff, MA (Cincinnati Children's Hospital)
No relevant financial relationships

Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children’s Hospitals in the United States
Presenter: Alicia Diaz-Thomas, MD, MPH (Le Bonheur Children's Hospital)
No relevant financial relationships